Our first-in-class Transmembrane Carbohydrate Immunostimulants have demonstrated PD-1-level efficacy in mice models.
Aceman Pharma Oy is a pioneering biotechnology research company dedicated to the discovery and development of innovative immunostimulatory compounds. Originating as a spin-off from the esteemed University of Turku and Åbo Akademi, Aceman Pharma Oy is focused on advancing novel therapeutic solutions for oncology and other significant indications. Our commitment to cutting-edge research drives us to create impactful advancements in the field of biotechnology.
Aceman Pharma Oy specializes in first-in-class Transmembrane Carbohydrate Immunostimulants, which have demonstrated remarkable PD-1-level efficacy in mice models. With a strong foundation in oncology, immunology, and allergy research, Aceman Pharma Oy is dedicated to translating groundbreaking scientific discoveries into tangible benefits for patients. The company’s primary address is located at 20500 Turku, Finland 20500, FI.
At Aceman Pharma Oy, we are committed to pushing the boundaries of biotechnology to deliver transformative healthcare solutions. We invite the management of Aceman Pharma Oy to enhance your company's visibility and attract new commercial opportunities by creating a customized and exclusive company showcase and product listing on our platform.
Aceman Pharma Oy on uraauurtava bioteknologian tutkimusyritys, joka on omistautunut innovatiivisten immunostimulatoristen yhdisteiden löytämiselle ja kehittämiselle. Alun perin Turun yliopiston ja Åbo Akademin spin-off-yrityksenä Aceman Pharma Oy keskittyy edistämään uusia terapeuttisia ratkaisuja onkologiaan ja muihin merkittäviin käyttöaiheisiin. Sitoutumisemme huippututkimukseen ajaa meitä luomaan vaikuttavia edistysaskeleita bioteknologian alalla.
Aceman Pharma Oy on erikoistunut ensimmäisen luokan transmembraanikarbohydraatti-immunostimulantteihin, jotka ovat osoittaneet huomattavaa PD-1-tason tehokkuutta hiirimalleissa. Vahvan onkologian, immunologian ja allergian tutkimuksen pohjalta Aceman Pharma Oy on sitoutunut kääntämään uraauurtavia tieteellisiä löytöjä konkreettisiksi hyödyiksi potilaille. Yrityksen pääosoite on 20500 Turku, Suomi 20500, FI.
Aceman Pharma Oy:ssä olemme sitoutuneet edistämään bioteknologian rajoja toimittaaksemme mullistavia terveydenhuollon ratkaisuja. Kutsumme Aceman Pharma Oy:n johtoa parantamaan yrityksesi näkyvyyttä ja houkuttelemaan uusia kaupallisia mahdollisuuksia luomalla räätälöidyn ja eksklusiivisen yritysesittelyn ja tuoteluettelon alustallamme.
Compare Aceman Pharma Oy with 3 companies in Biotechnology-Research
| Comparison Field |
Aceman Pharma OyMain Company |
Rochester Regional H...View Profile |
Merus N.V.View Profile |
Allergy Partners PLL...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2014 | ||
|
Company Size
|
— | 10,001+ | 201-500 | 1,001-5,000 |
|
City
|
Turku, Finland | Rochester, New York | Utrecht, Utrecht | Asheville, North Carolina |
|
Country
|
United States | Netherlands | United States | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Immunostimulants
Oncology Research
Immunology
Pharmaceuticals
Therapeutic Solutions
Drug Development
oncology
immunology
allergy
|
20 Total
20 Unique
Unique Skills:
bariatric surgery
behavioral health services
cardiology
elderly services
endocrinology
gynecology
+14
|
10 Total
10 Unique
Unique Skills:
antibody discovery
antibody engineering
biomarker development
cell biology
early discovery
functional assays
+4
|
1 Total
1 Unique
Unique Skills:
asthma
|
Other organizations in the same industry
This company is also known as